A new indolocarbazole derivative in melanoma and carcinoma lung in vivo treatment
Abstract Objective The current scientific research direction is development of drugs with a targeted effect on malignant tumors. One of the promising groups is indolocarbazoles and their derivatives, which can initiate various tumor cell death pathways. Russian scientists from N. N. Blokhin National...
Guardado en:
Autores principales: | Anna Lantsova (Autor), Irina Golubeva (Autor), Larisa Borisova (Autor), Lyudmila Nikolaeva (Autor), Lydia Ektova (Autor), Maria Dmitrieva (Autor), Olga Orlova (Autor) |
---|---|
Formato: | Libro |
Publicado: |
BMC,
2021-04-01T00:00:00Z.
|
Materias: | |
Acceso en línea: | Connect to this object online. |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development and validation of HPLC method for analysis of indolocarbazole derivative LCS-1269
por: Zoya Shprakh, et al.
Publicado: (2021) -
ANTITUMOR DRUGS BASED ON INDOLOCARBAZOL DERIVATIVES
por: I. P. Kolpaksidi, et al.
Publicado: (2021) -
Antiproliferative activity of a new derivative from the class of N-glycoside of indolo[2,3-a]pyrrolo[3,4-c]carbazoles
por: Marina P. Kiseleva, et al.
Publicado: (2022) -
The Development of a Parenteral Pharmaceutical Formulation of a New Class of Compounds of Nitrosourea
por: Ludmila Nikolaeva, et al.
Publicado: (2016) -
MODERN ONCO DRUG FOR INTERNAL USE
por: O. L. Orlova, et al.
Publicado: (2018)